These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 5108387)

  • 1. Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.
    Weibel RE; Stokes J; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 May; 216(6):983-6. PubMed ID: 5108387
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined live measles, mumps, rubella vaccine. Immunological response.
    Krugman S; Muriel G; Fontana VJ
    Am J Dis Child; 1971 May; 121(5):380-1. PubMed ID: 5091532
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined live measles, mumps, and rubella virus vaccines.
    Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
    Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
    Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
    Saidi S; Naficy K
    Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M; Berger R; Glück R; Wegmann A
    Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and serological studies of live attenuated mumps virus vaccine--inoculation of mumps vaccine singly and in combination with measles vaccine].
    Kawanishi K
    Kansenshogaku Zasshi; 1971 Feb; 45(2):54-66. PubMed ID: 4995912
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination with RA 27-3 attenuated rubella virus.
    Puschak R; Young M; McKee TV; Plotkin SA
    J Pediatr; 1971 Jul; 79(1):55-60. PubMed ID: 5091268
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines.
    Ozaki K; Kuno-Sakai H; Kimura M
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):305-11. PubMed ID: 3508655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Rubella virus vaccine, live".
    Clin Pediatr (Phila); 1970 Dec; 9(12):15A passim. PubMed ID: 5487471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.